BIOMX INC's ticker is PHGE and the CUSIP is 09090D103. A total of 16 filers reported holding BIOMX INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,602,828 | -2.2% | 4,553,489 | 0.0% | 0.03% | +13.3% |
| Q2 2023 | $1,639,256 | +70.0% | 4,553,489 | +44.0% | 0.03% | +57.9% |
| Q1 2023 | $964,254 | +83.6% | 3,161,489 | +12.4% | 0.02% | +90.0% |
| Q4 2022 | $525,278 | -45.1% | 2,813,489 | 0.0% | 0.01% | -44.4% |
| Q3 2022 | $957,000 | -53.4% | 2,813,489 | 0.0% | 0.02% | -51.4% |
| Q2 2022 | $2,054,000 | -62.2% | 2,813,489 | 0.0% | 0.04% | -58.0% |
| Q1 2022 | $5,430,000 | +20.6% | 2,813,489 | 0.0% | 0.09% | +51.7% |
| Q4 2021 | $4,502,000 | -47.7% | 2,813,489 | 0.0% | 0.06% | -38.9% |
| Q3 2021 | $8,609,000 | -31.8% | 2,813,489 | +21.6% | 0.10% | -25.8% |
| Q2 2021 | $12,632,000 | -23.3% | 2,313,489 | 0.0% | 0.13% | -16.9% |
| Q1 2021 | $16,472,000 | +11.6% | 2,313,489 | 0.0% | 0.15% | +19.4% |
| Q4 2020 | $14,760,000 | +0.6% | 2,313,489 | 0.0% | 0.13% | -29.9% |
| Q3 2020 | $14,668,000 | +14.9% | 2,313,489 | 0.0% | 0.18% | +2.2% |
| Q2 2020 | $12,770,000 | -21.1% | 2,313,489 | 0.0% | 0.18% | -33.8% |
| Q1 2020 | $16,194,000 | -27.7% | 2,313,489 | 0.0% | 0.27% | -15.0% |
| Q4 2019 | $22,406,000 | – | 2,313,489 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,133,402 | $398 | 0.12% |
| MMCAP International Inc. SPC | 684,451 | $127,787 | 0.01% |
| Orbimed Advisors | 2,813,489 | $525,278 | 0.01% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 41,409 | $7,731 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 10,624 | $1,984 | 0.00% |
| Walleye Capital LLC | 13,556 | $2,531 | 0.00% |
| Renaissance Technologies | 39,400 | $7 | 0.00% |
| JANE STREET GROUP, LLC | 59,768 | $11,159 | 0.00% |
| UBS Group AG | 29,893 | $5,680 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 49,500 | $9,242 | 0.00% |